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We stripped human red blood cell membranes of cytoskeleton proteins at pH 12 without reductant, partially solubilized the obtained
vesicles by use of octaethylene glycol n-dodecyl ether and purified the glucose transporter GLUT1 by anion-exchange chromatography
followed by sulfhydryl-affinity chromatography, which removed most of the nucleoside transporter (NT) and the lipids. Eighty percent of the
sulfhydryl-bound GLUT1 could be eluted with sodium dodecyl sulfate (SDS) indicating that the bound protein was multimeric. Matrix-
assisted laser desorption ionization-time of flight-mass spectrometry (MALDI-ToF-MS) of the trypsinized major SDS-PAGE zone of the
purified material identified GLUT1 but no other membrane protein. Transmembrane helices 1 and 8 were among the detected fragments. The
reconstituted purified GLUT1 showed glucose transport activity, although only approximately 0.05 high-affinity cytochalasin B (CB) binding
sites were present per GLUT1 monomer. The vesicles used as starting material for the purification showed 0.4 CB sites per GLUT1
monomer, similar to vesicles prepared in the presence of dithioerythritol. The data are consistent with the coexistence of monomeric GLUT1
with high-affinity CB-binding activity and preferentially solubilized multimeric GLUT1 with no CB-binding activity in the red blood cell
membrane vesicles prepared without reductant.
D 2003 Elsevier B.V. All rights reserved.Keywords: Cytochalasin B; Glucose transporter GLUT1; Human red blood cell; Nitrobenzylthioinosine; Nucleoside transporter; Sulfhydryl-affinity
chromatography1. Introduction
The glucose transporters GLUT1–12 [1–5] belong to a
family of facilitative glucose transporters and are distributed
among different tissues and organs in mammalians. They are0005-2736/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2003.10.001
Abbreviations: A-GLUT1, anion-exchange-purified GLUT1 prepared
without reductant; A-GLUT1DTE, anion-exchange-purified GLUT1 pre-
pared in the presence of dithioerythritol; A-GLUT1(DTE), anion-exchange-
purified GLUT1 prepared without reductant from membrane vesicles
cytoskeleton-depleted in the presence of dithioerythritol; CaPE, calcium
phosphate adsorption and ethanol precipitation; CB, cytochalasin B; C12E8,
octaethylene glycol n-dodecyl ether; pCMB, p-chloromercurybenzoic acid;
DMPC, 1,2-dimyristoyl-1-sn-glycerol-3-phosphocholine; DTE, dithioery-
thritol; EYP, egg yolk phospholipids; MALDI-ToF-MS, matrix-assisted
laser desorption ionization-time of flight-mass spectrometry; NBTI, nitro-
benzylthioinosine; NT, nucleoside transporter; SDS, sodium dodecyl
sulfate; S-GLUT1, sulfhydryl-affinity-purified GLUT1 prepared without
reductant; S-GLUT1(DTE), sulfhydryl-affinity-purified GLUT1 prepared
without reductant from membrane vesicles cytoskeleton-depleted in the
presence of dithioerythritol
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GLUT1 [2] is present in red blood cells and epithelial cells,
for example, in the blood–brain barrier, and can be purified
from solubilized cytoskeleton-depleted red blood cell mem-
brane vesicles on anion exchangers, such as DEAE-cellulose
[6–8], aminoethyl-Sepharose 4B [9] and HiTrap Q [10]. The
nucleoside transporter (NT) is a minor component (3–5% by
weight) of these GLUT1 preparations [11,12].
Binding of competitive inhibitors to membrane proteins
has been analyzed to study the association state of
membrane proteins. Human red blood cell membranes,
membrane vesicles and proteoliposomes showed 0.4 to 1
cytochalasin B (CB) binding sites per GLUT1 monomer
[7,13–19], as revealed by equilibrium dialysis [7], fluo-
rescence quenching [16] and frontal affinity chromatogra-
phy [15]. Frontal affinity chromatography at steady state
on immobilized biomembranes affords accurate Kd values
and numbers of binding sites [11,13,15,19–21]. Advan-
tages of this method for studying membrane proteins have
been reviewed [22,23]. Kd values of 60–100 nM were
determined for CB binding to GLUT1 purified in the
presence of dithioerythritol (DTE) [11,13,15]. These val-
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in membrane vesicles [13,16] and red blood cells [19].
Values of 200–400 nM were reported for GLUT1 purified
without reductant as determined by fluorescence quench-
ing [14,18]. The competitive NT inhibitor nitrobenzylth-
ioinosine (NBTI) shows high affinity for NT in various
membranes (dissociation constant, Kd, 0.04–0.4 nM)
[11,21] but binds less strongly to reconstituted GLUT1
(Kd 80 nM) [11]. Among the proposals regarding the
native oligomeric state of GLUT1 [7,13,18], the most
accepted one is that GLUT1 exists as tetramer with 0.5
CB binding site per GLUT1 monomer [18]. However, the
reported effect of reductant to increase the number of CB
binding sites per GLUT1 monomer [18] could not be
confirmed [13]. The presence of reductant has also been
reported to affect the association state of the purified
GLUT1 [14,18].
In the present study, we purified GLUT1without reductant
by use of anion-exchange chromatography followed by
sulfhydryl-affinity chromatography [9,24] with analysis of
glucose transport and CB binding activities. Matrix-assisted
laser desorption ionization-time of flight-mass spectrometry
(MALDI-ToF-MS) [25] of tryptic peptide fragments was
used to identify the protein. We interpreted our results to
give a new view of the putative oligomeric state of GLUT1 in
the red blood cell membranes.2. Materials and methods
2.1. Materials
We purchased CNBr-activated Sepharose 4B, Superdex
75 and 200, prep grade, and 0.5 cm (i.d.) 5 cm HR glass
columns from Amersham Biosciences (Uppsala, Sweden);
1,2-dimyristoyl-1-sn-glycerol-3-phosphocholine (DMPC)
from Avanti Polar Lipids (Alabaster, AL, USA); sodium
dodecyl sulfate (SDS) from BDH (Poole, Dorset, UK);
octaethylene glycol n-dodecyl ether (C12E8) from Fluka
(Buchs, Switzerland); [4-3H]CB, [benzyl0-3H]NBTI, L-
[1-3H] glucose and D-[14C(U)] glucose from NEN (Boston,
MA, USA); 1-ethyl-3-(3-dimethylaminopropyl)carbodii-
mide–HCl from Pierce (Rockford, IL, USA); trypsin solu-
tion (modified, sequence grade) from Promega (Madison,
WI, USA); adenosine, CB, DTE, NBTI and p-chloromer-
curybenzoic acid (pCMB) from Sigma (St. Louis, MO,
USA) and DEAE cellulose (DE-52) from Whatman (Maid-
stone, Kent, UK). Egg yolk phospholipids (EYP) were
prepared as described in Ref. [26].
Buffer Awas 70 mM Tris–HCl, pH 7.0, containing 1 mg/
ml C12E8; buffer B was 70 mM Tris–HCl, pH 7.0, contain-
ing 1 mg/ml C12E8 and 1 mg/ml DMPC; eluent A was 200
mM NaCl, 50 mM D-glucose, 3 mM NaN3 and 10 mM
sodium phosphate, pH 7.2; and eluent B was 150 mM NaCl,
1 mM Na2EDTA and 10 mM Tris–HCl, pH 7.4. The pH
values were measured at 23 jC.2.2. Phosphorus analysis, protein assays and amino acid
analysis
We determined phosphorus amounts after sulfuric-acid
oxidation essentially according to Bartlett [27]. Protein
assays were chosen depending on the components in the
sample. (a) We determined the protein amount in the
GLUT1 sample prepared by anion-exchange chromatogra-
phy (Section 2.3) by a micro-Bradford assay with calcium
phosphate adsorption and ethanol precipitation (CaPE) [28]
to eliminate the effects of endogenous lipids and C12E8. For
this assay we solubilized proteoliposomes by mixing 30 Al of
proteoliposome sample with 70-Al 10% (v/v) Triton X-100.
Reagent controls with liposomes showed the same results as
without liposomes. (b) For GLUT1 prepared by sulfhydryl-
affinity chromatography (Section 2.4), we used the original
micro-Bradford assay [29] due to the low amount of
endogenous lipids and C12E8. (c) The protein of immobi-
lized proteoliposomes, SDS-eluted protein from the pCMB-
Sepharose 4B gel and the protein remaining bound on the
gel after SDS elution were quantitated by hydrolysis with 6
M HCl for 24 h followed by automated amino acid analysis.
The data were refined as in Ref. [13].
2.3. Preparation of membrane vesicle, A-GLUT1 and
A-GLUT1(DTE)
We prepared red blood cell membranes from cell con-
centrates (stored 5–7 weeks after blood donation) obtained
from the Blood Bank at the University Hospital, Uppsala,
Sweden, and stripped off the cytoskeleton at pH 10.5 and
pH 12 as described in Ref. [8], except that no reductant was
included in the pH-12 solution. We solubilized thawed
vesicles for 20 min on ice by use of 22 mg/ml C12E8 in
70 mM Tris buffer, pH 7.4, at 8 mg protein/ml, centrifuged
the material at 160,000 g for 1 h to obtain a supernatant
containing up to 65% by weight of the vesicle protein,
applied the supernatant onto a DEAE-cellulose column
equilibrated with buffer A (5 mg protein/ml gel bed) and
collected the break-through material, the anion-exchange-
purified GLUT1 (A-GLUT1).
We also purified GLUT1 from red blood cell membrane
vesicles prepared as described previously with 0.2 mM DTE
in the pH 12-solution for cytoskeleton stripping [8], but
omitted DTE from the solubilization mixture and from the
buffer for anion-exchange chromatography. This preparation
was denoted A-GLUT1(DTE). The chromatographic purifi-
cations were performed at 5 jC.
2.4. Preparation of S-GLUT1 and S-GLUT1(DTE)
In order to synthesize pCMB-Sepharose 4B essentially
as in Refs. [9,24], we suspended freeze-dried CNBr-acti-
vated Sepharose 4B gel (15 g) in 1 mM HCl, washed it on
a Bu¨chner funnel with 3 l of 1 mM HCl for 15 min, mixed
the gel with a chilled solution of 19 ml of ethylenediamine
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Fig. 1. SDS-PAGE of GLUT1: A-GLUT1(DTE) (lane 1) and S-GLUT1(DTE)
(lane 2). A-GLUT1(DTE) was purified by anion-exchange chromatography
and S-GLUT1(DTE) was prepared by sulfhydryl-affinity chromatography of
A-GLUT1(DTE) on pCMB-Sepharose 4B (see Fig. 2). For details, see
Section 2. The band 4.5 is marked, which is known to contain GLUT1 and
NT [8]. The arrow indicated the position of the marker protein glutamic
dehydrogenase (55.4 kDa). Approximately 1.5-Ag protein was loaded to
each well.
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12 M HCl, shook the suspension gently overnight at 4jC,
washed the synthesized aminoethyl-Sepharose 4B with 4
l of chilled water on a Bu¨chner funnel, resuspended the gel
in 27 ml of 40% dimethylformamide at 23 jC, supple-
mented the suspension with 0.3 g of pCMB, adjusted the
pH to 4.8 by addition of 5-Al aliquots of 2 M HCl during 1
h, transferred the suspension to a bottle for gentle shaking
overnight, decanted the gel from pCMB particles six times
and washed the gel on a Bu¨chner funnel during 6 h with 4
l of 0.1 M NaHCO3–HCl, pH 8.9, and finally with 1-
l water. The addition of dimethylformamide and the
subsequent procedures were repeated once. The pCMB-
Sepharose 4B gel was stored at 4 jC in 0.2 mg/ml NaN3
and bound approximately 100 mg of human hemoglobin
per milliliter of sedimented gel, similarly as reported in
Ref. [30]. The binding capacity was retained for at least 2
years.
We packed the pCMB-Sepharose 4B in a 0.5 cm
(i.d.) 5 cm HR glass column up to 2 mm below the end
of the central part of the tube (the threaded ends were
slightly wider) with the outlet of the tubing 6 cm below the
buffer surface, rinsed with 70 mM Tris–HCl, pH 7.4, gently
inserted the end adaptor down to the gel surface without
locking the screw, and equilibrated with buffer A at a flow
rate of 0.1 ml/min. The loose packing of the gel bed and the
low flow rate favored the binding of protein. We applied A-
GLUT1 or A-GLUT1(DTE), washed with buffer A or B until
a stable absorbance baseline was reached and eluted the
bound material with buffer A or B supplemented with 0.2%
(v/v) 2-mercaptoethanol to obtain sulfhydryl-affinity-puri-
fied GLUT1; namely, S-GLUT1 or S-GLUT1(DTE), respec-
tively. The chromatographic purifications were performed at
5 jC. We found 70–90 mM Tris–HCl at pH 7.4–7.8
suitable for A-GLUT1 binding and elution, whereas A-
GLUT1 bound in 5 mM phosphate buffer, pH 8.0, could
not be eluted by 2-mercaptoethanol in either the phosphate
buffer or buffer B.
2.5. SDS-PAGE
We ran 12-Al aliquots of protein samples (10 Al)
mixed with an equal volume of 2 sampling buffer
containing 0.125 M Tris–HCl, pH 6.8, 20% (v/v) glyc-
erol, 4% (w/v) SDS and 0.005% (w/v) bromophenol blue,
on 4 12% Tris glycine polyacrylamide gels (1.0-mm
thick, 15-well) for 1.5 h at 125 V with a running buffer
of 25 mM Tris base, 192 mM glycine and 1 mg/ml SDS.
The wide-range protein standard Mark12 was applied. No
DTE was added to the sample mixture. The SDS-PAGE
materials were obtained from Novex (San Diego, CA,
USA). The gel was fixed by an acetone solution con-
taining formalin, sensitized by use of sodium thiosulfate,
stained with silver nitrate and developed by use of
sodium carbonate followed by addition of acetic acid
[31].2.6. In-gel digestion and mass spectrometry
In order to identify the GLUT1 samples, we excised the
stained area of band 4.5 in the SDS-PAGE gels, which
showed patterns similar to those illustrated in Fig. 1, and
treated the gel piece for in-gel digestion as described [25].
Briefly, the gel pieces were washed with ammonium bicar-
bonate buffer in acetonitrile, dried, and a trypsin solution
was allowed to be absorbed into the re-swelling gel. After
overnight incubation and acidification, the generated pep-
tides were extracted and analyzed by Peptide Mass Finger-
printing in the MALDI-ToF-MS instrument (Bruker
Autoflex, Bruker Daltonics, Bremen, Germany).
Samples for MALDI were prepared by the ‘‘dried drop-
let’’ technique, using a-cyano 4-hydroxycinnamic acid as
matrix. The instrument was optimized for peptide analysis
and calibration was performed internally using autolytic
peptides from the porcine trypsin used.
We searched for protein identity with the determined
peptide masses in ProFound against a non-redundant protein
sequence database (NCBInr).
2.7. Reconstitution and immobilization
We applied a mixture of EYP solution (1.5 ml) and
GLUT1 sample (2.5 ml) onto a 2 cm (i.d.) 35 cm Super-
dex 75 gel bed as described in Ref. [20] in order to
reconstitute the protein. For glucose transport measure-
ments, we used eluent A as the reconstitution buffer and
collected the frontal half of the proteoliposome zone, froze
200-Al aliquots of the proteoliposome suspension in poly-
propylene tubes at  23 jC in a temperature-controlled
ysica Acta 1618 (2003) 8–16
Fig. 2. Sulfhydryl-affinity chromatography of A-GLUT1(DTE) on pCMB-
Sepharose 4B: a–b, application; b–c, washing with buffer A; c–d, elution
of S-GLUT1(DTE) with buffer A containing 0.2% (v/v) 2-mercaptoethanol.
The bars show the concentration of endogenous phospholipids. The part of
the S-GLUT1(DTE) zone of absorbance above 0.2 was collected.
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and thawed aliquots in a water bath at 25 jC 10 min before
use. For frontal affinity analysis, eluent B was the reconsti-
tution buffer and the whole zone was collected and approx-
imately 16-fold concentrated in a Minicon B15 cell
(Millipore, Bedford, MA, USA); immobilization of proteo-
liposomes and vesicles in Superdex 75, packing and wash-
ing of the gel bed were essentially as described in Ref. [20].
2.8. Glucose transport measurements
For determination of the equilibrium-exchange of D-
glucose, we mixed proteoliposomes (150 Al) at 22 jC with
eluent A (75 Al) supplemented with D-[14C]glucose and L-
[3H]glucose, incubated for 0, 40, 60 and 120 s, respectively,
added 75 Al of eluent A with 10 mM HgCl2 to stop the
transport and injected the sample from a 200-Al loop into a
0.5 cm (diam.) 18 cm gel bed of Superdex 75 for size-
exclusion separation of proteoliposomes from free radioac-
tive glucose [20]. Leakage was compensated for as described
in Ref. [32]. The difference between the uptake of D- and L-
glucose (mmol g 1 s 1) in the proteoliposomes represents
the D-glucose transport.
2.9. Frontal affinity chromatographic analysis of inhibitor
binding
For frontal analysis of inhibitor binding to membrane
proteins in immobilized proteoliposomes or vesicles in a 0.5
cm (i.d.) 5 cm HR glass column, we connected the
column to a 50-ml Superloop (Amersham Biosciences)
and an on-line flow-scintillation detector (Radiomatic
FLO-ONE 500TR, Packard Instruments, Meriden, CT,
USA) [11,15]. Before each run we equilibrated with 10
column volumes of the sample solution without inhibitor
and then applied series of large-volume samples: (a) 1150
nM CB including 1 nM [3H]CB, (b) 1 nM [3H]CB in the
presence of 0–150 mM D-glucose, (c) 0.110 nM NBTI
containing 0.1 – 0.4 nM [3H]NBTI and (d) 0.4 nM
[3H]NBTI in the presence of 0 10 mM adenosine at a
flow rate of 1 ml/min. The CB binding to GLUT1 and the
binding of NBTI to both NT and GLUT1 were evaluated as
described in Refs. [11,15].1 The residual DTE in the vesicle suspension (approximately 5 AM
after cytoskeleton-depletion in the presence of 0.2 mM DTE and washing
once with Tris-HCl buffer [8]) was diluted two-fold upon anion exchange
chromatography to obtain A-GLUT1(DTE) and did not affect the binding of
A-GLUT1(DTE) to pCMB-Sepharose 4B significantly.3. Results
3.1. Purification of the glucose transporter GLUT1
A-GLUT1(DTE) (Fig. 1, lane 1) and A-GLUT1 (not
illustrated), obtained by anion exchange chromatography
of solubilized red blood cell membranes that had been
stripped of cytoskeletal proteins in the presence of 0.2
mM DTE and without reductant, respectively, both showed
the broad major band 4.5 representing the heterogeneously
glycosylated monomeric transporter in SDS-PAGE. A-GLUT1DTE, obtained by anion-exchange chromatography
in the presence of 1 mM DTE of solubilized red blood cell
membranes depleted of their cytoskeleton at high pH in the
presence of 0.2 mM DTE, showed a similar SDS-PAGE
pattern [8].
Following application of A-GLUT1(DTE)
1 or A-GLUT1
onto a pCMB-Sepharose 4B gel bed, we washed away
endogenous lipids and released S-GLUT1(DTE) (Fig. 2) or
S-GLUT1, respectively, by use of 2-mercaptoethanol. These
materials contained 7 and 30 endogenous phospholipid
molecules, respectively, per GLUT1 monomer, whereas
the corresponding value for A-GLUT1 was 180. The con-
centration of the eluted S-GLUT1(DTE) was up to 0.5 mg/ml.
The S-GLUT1(DTE) (Fig. 1, lane 2) and S-GLUT1 (not
illustrated) showed the same pattern on SDS-PAGE as did
the anion-exchange purified materials.
MALDI-ToF-MS identified tryptic fragments of GLUT1
(Table 1). Fragments in the hydrophilic loops connecting
transmembrane helices 3 and 4 and transmembrane helices 6
and 7 of both S-GLUT1 and S-GLUT1(DTE) were detected.
Parts of the C-terminal polypeptides were also identified for
both preparations. The complete transmembrane helices 1
and 8 were found for S-GLUT1 and A-GLUT1, but not for S-
GLUT1(DTE) or A-GLUT1(DTE). No fragments from other
Table 1
Fragments in MALDI-ToF-MS of tryptic GLUT1a
S-GLUT1(DTE) S-GLUT1
Residues Position Residues Position
118–126 L3–4 12–38 H1
256–264 L6–7 118–126 L3–4
257–264 L6–7 233–249 L6–7
459–468 C terminus 256–264 L6–7
478–492 C terminus 301–330 H8
459–492 C terminus
a The locations of the fragments in the amino acid sequence of GLUT1
are given. H1 is the transmembrane a-helical domain of GLUT1 [1], etc.
L3–4 is the hydrophilic loop between the two transmembrane domains 3
and 4, etc. The C terminus is cytoplasmic.
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ToF-MS in our GLUT1 preparations. However, amino acid
analyses indicated that the A- and S-GLUT1 preparations
were slightly impure. Minor contaminants are NT, hemoglo-
bin and glyceraldehyde-3-phosphate dehydrogenase. Un-
known proteins may be present in the preparations.
Eighty percent of the A-GLUT1 bound in the pCMB-
Sepharose 4B gel bed could be released by 5% SDS, but
not with 0.5% SDS (Fig. 3A). SDS presumably released
noncovalently bound monomers in the oligomer. The
material that did not elute with 5% SDS was presumably
bound by -S–Hg2 +- bridges and could be released with 2-
mercaptoethanol (Fig. 3B, lower curve). The result indi-
cates that A-GLUT1, on the average, formed pentamers.
The amount of S-GLUT1 initially bound in the pCMB-Fig. 3. Partial elution by SDS washing of A-GLUT1 bound on pCMB-Sepharose
buffer B containing 0.5% SDS; d–e, elution with buffer B containing 5% SDS wa
Quantitation of the amount of A-GLUT1 bound on pCMB-Sepharose 4B and of th
the protein began to elute, washed the column either with buffer A alone (x) or
sectioned the gel beds by Pasteur pipetting and released the bound GLUT1 by 2%
original micro-Bradford assay [29]. The x-axis shows the distance in the columnSepharose 4B gel bed is also shown in Fig. 3B (top curve).
A larger fraction of the bound protein was released by SDS
at the top part of the gel bed than at the lower part,
indicating that large oligomers were preferentially bound
at the top of the gel bed by -S–Hg2 +- bridges linking a
single monomer of each oligomer to the gel.
3.2. Affinity of and binding sites for inhibitors on red blood
cell membrane vesicles, A-GLUT1 and S-GLUT1
Immobilized S-GLUT1 and A-GLUT1 showed indistin-
guishable dissociation constants of inhibitors and substrates,
similar to those of A-GLUT1DTE, except for the Kd for
adenosine binding on GLUT1 (Table 2). However, the
number of CB-binding sites per A-GLUT1 or S-GLUT1
monomer was dramatically lower than that for vesicles or A-
GLUT1DTE (the latter according to data from Ref. [11])
(Table 3). S-GLUT1(DTE) purified from the partially solubi-
lized membrane vesicles stripped with alkaline solution
containing 0.2 mM DTE showed no significant CB-binding
activities upon analysis by frontal affinity chromatography.
The molar ratio of NBTI-binding sites on the minor impu-
rity, NT, over the total amount of S-GLUT1 protein (as-
suming a molecular weight of 54,117) was 1/7 of the
corresponding ratio for A-GLUT1 (Table 3) and 1/36 of
that for A-GLUT1DTE (the latter according to data from Ref.
[11]). The A- and S-GLUT1 showed a number of NBTI
binding sites per GLUT1 monomer that was 50% and 30%,
respectively, of the number of NBTI binding sites per A-4B. (A) a–b, application; b–c, washing with buffer B; c–d, washing with
rmed to 30 jC to keep the SDS in solution; e– f, washing with buffer A. (B)
e amount remaining bound after SDS washing. We applied A-GLUT1 until
with buffer B containing 5% SDS followed by buffer A (n) as in Fig. 3A,
2-mercaptoethanol in buffer A. The protein amounts were quantitated by the
from the top of the gel bed.
Fig. 4. Specific D-glucose equilibrium exchange (percent of 50 mM D-
glucose) by S-GLUT1 reconstituted with EYP. The exchange of L-glucose
has been subtracted. The protein concentration in the proteoliposomes was
46 Ag/ml.
Table 2
Dissociation constants of CB, glucose (Glc), NBTI and adenosine (Ad)
interacting with GLUT1 or NT in red blood cell membrane vesicles and
reconstituted GLUT1 preparations (proteoliposomes), all immobilized in
Superdex 200 and analyzed by frontal affinity chromatography
Preparation CB-
GLUT1
(nM)
Glc-
GLUT1
(mM)
NBTI-
NT
(nM)
Ad-
NT
(nM)
NBTI-
GLUT1
(nM)
Ad-
GLUT1
(mM)
A-GLUT1 38 20 0.35 24 43 4.6
S-GLUT1 35 30 0.31 23 55 8.2
A-GLUT1DTE
a 61 41 0.38 21 79 0.2
Vb 29 26 0.15 Ndc –d – d
VDTE
e 59 18 0.16 Ndc –d – d
Estimated relative error limit: F 15%.
a A-GLUT1DTE, data from Ref. [11].
b V, red blood cell membrane vesicles prepared without reductant.
c Nd, not determined.
d – , no measurable interaction.
e VDTE, red blood cell membrane vesicles prepared with reductant, data
from Refs. [13,21].
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No NBTI-binding sites on GLUT1 in red blood cell mem-
brane vesicles stripped without reductant could be detected,
similarly as reported for vesicles stripped with reductant
[33] and red blood cell ghosts [34,35]. For the above
calculations, GLUT1 was assumed to represent 12% of
the total protein amount in vesicles [13].
3.3. Glucose transport activity
The S-GLUT1 showed glucose transport activity after
reconstitution (Fig. 4). The equilibrium exchange for S-
GLUT1 eluted without added lipids at 50 mM glucose was
0.80F 0.02 mmol g 1 s 1 for 1-min incubation, similar to
the reported values of 1.1 mmol g 1 s 1 for GLUT1 with a
20-s incubation [20] and 0.35F 0.04 and 0.43F 0.03 mmolTable 3
The number of binding sites of CB and NBTI per GLUT1 monomer in
membrane vesicles and GLUT1 proteoliposomes
Preparation NT-Ta CB-Tb NBTI-Tc
A-GLUT1 0.0035 0.066 0.31
S-GLUT1 0.0005 0.028 0.19
A-GLUT1DTE
d 0.018 0.40 0.59
Vd 0.018 0.41 – e
VDTE
d 0.029 0.51 – e
Estimated relative error limit: F 15%.
a NT–T, the molar ratio of NBTI sites on NT over the total amount of
protein molecules in the column when the molecular weight of all the
protein was taken as 54117 (GLUT1).
b CB–T, the ratio of CB sites on GLUT1 over the total amount of
protein molecules in the column when the molecular weight of all the
protein was taken as 54117.
c NBTI–T, the ratio of NBTI sites on GLUT1 over the total amount of
protein molecules in the column when the molecular weight of all the
protein was taken as 54117.
d As described in Table 2.
e – , no measurable interaction.g 1 s 1 without and with lipids, respectively, with a 2-min
incubation [17].4. Discussion
In our study, no GLUT1 oligomers were observed on
SDS-PAGE for GLUT1 in vesicles (not shown). However,
treatment of membrane vesicles with reductant can convert
the multiple oligomeric bands of the oxidized anion trans-
porter, the major component of red blood cell membrane
vesicles, into a single monomeric band on SDS-PAGE [36].
The partial solubilization without reductant of membrane
vesicles stripped without or with reductant may be related to
the cross-linking of anion transporters in the vesicles. If a
protein appears simultaneously in different states in the
vesicles, incomplete and selective solubilization of the
vesicles would critically affect the characterization of the
membrane protein.
Different association states of GLUT1 in the red blood
cell membranes have been indicated in earlier studies
[14,37–39]. The immunofluorescence staining of human
red blood cells showed an uneven distribution of GLUT1
over the red blood cell membranes [37]. GLUT1 in red blood
cell vesicles stripped with reductant was solubilized mostly
as monomers by n-octyl b-D-glucopyranoside or C12E8
[17,40] and GLUT1 in red blood cell vesicles stripped
without reductant was solubilized mostly as tetramers by
cholate [14,18]. Multimers up to octamers with glucose
transport activity have been observed by cholate solubiliza-
tion of non-stripped human red blood cell ghosts [38].
Alkaline reduction caused conversion from oligomeric
Fig. 5. Schematic illustration of hypothetical GLUT1 association states in red blood cells and red blood cell membrane vesicles stripped without reductant and
in membrane vesicles stripped in the presence of reductant. The native monomeric GLUT1 represents 40% of the total GLUT1 molecules and the ratio of
tetramers to octamers is 3:1. The monomers formed from the oligomeric GLUT1 do not bind CB significantly compared to the native GLUT1 monomers.
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our study, the competitive inhibitor CB bound similarly, at a
ratio of 0.4–0.5 sites per GLUT1 monomer, to GLUT1 in the
vesicles stripped without and with reductant (Table 3).
However, GLUT1 partially solubilized and purified without
reductant from vesicles stripped with or stripped without
reductant did not attain the CB-binding ratio of 0.4 reported
previously for GLUT1 purified in the presence of reductant
[13]. The ratio was found to be much lower for the C12E8-
solubilized GLUT1 prepared without reductant (Table 3),
which showed on the average pentamers to judge by SDS
washing of GLUT1 bound on the pCMB gel bed (Fig. 3).
The few but similarly active CB-binding sites in A-GLUT1
and S-GLUT1 proteoliposomes compared to A-GLUT1DTE
proteoliposomes (Table 2) implied that there are different
GLUT1 association states and that the partial solubilization
was selective, i.e., GLUT1 in a conformation which did not
favor CB binding was preferentially solubilized from
vesicles without reductant and these GLUT1 molecules were
natively oligomeric, averaged as pentamers according to our
analysis. We further speculate that CB-binding GLUT1
monomers represented approximately 40% of the GLUT1
in the vesicles as judged by the CB binding of GLUT1 in the
vesicles. Furthermore, it was harder to release this GLUT1
from the vesicles by the detergent compared to the oligo-
meric GLUT1. The oligomeric GLUT1 converts to mono-
mers by alkaline reduction, but this monomeric GLUT1 does
not necessarily show CB-binding activity, since vesicles
stripped without reductant did not differ significantly from
the vesicles stripped with reductant concerning the CB
binding site/GLUT1 monomer ratio [13]. MALDI-ToF-MS
revealed differences among the detected tryptic fragments
obtained from S-GLUT1(DTE), which may consist of newlyproduced monomeric GLUT1, and from S-GLUT1, which
probably consists of native oligomeric GLUT1 (Table 1).
The number of phospholipids per S-GLUT1 monomer of the
oligomeric material was 30, similar to the value 26 reported
in Ref. [14] for GLUT1 oligomers, i.e., more than the value 7
for the S–GLUT1(DTE).
We propose a scheme for the oligomeric states of GLUT1
in red blood cells or vesicles stripped without reductant and
in vesicles stripped with reductant (Fig. 5). The native
GLUT1 state might be a mixture of monomers, tetramers,
octamers and possibly other forms, in which the monomers
constitute approximately 40% of the total amount of
GLUT1. In this scheme, we combine the previously ob-
served monomeric and oligomeric states. The discrepancy
between this scheme and the proposition that GLUT1 in the
membranes is tetrameric [18] may be explained by the
selective partial solubilization of the vesicles, i.e., mainly
GLUT1 tetramers together with small amounts of monomers
and other forms were solubilized. The biological importance
of the putative multiple oligomeric states of GLUT1 is
uncertain. They might be related to the age of the protein
and/or provide a way to adjust the glucose transport activity.
Such a multiplicity of GLUT1 oligomeric states not only
complicates the characterization of GLUT1, but also hinders
both three-dimensional and two-dimensional crystallization.Acknowledgements
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